- ------------------------------------------------------ -------------------------
United States -------------------------
Securities and Exchange Commission SEC File Number
Washington, D.C. 20549 -------------------------
2-94117-D
FORM 12b-25
NOTIFICATION OF LATE FILING
-------------------------
CUSIP Number
-------------------------
595142 10 0
<TABLE>
- ------------------------------------------------------ -------------------------
<CAPTION>
<S> <C> <C> <C> <C> <C>
(Check One): [ ]Form 10-K [ ]Form 20-F [ ]Form 11-K [ X ]Form 10-Q [ ]Form N-SAR
</TABLE>
For Period Ended: June 30, 1996
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended:
-----------------------------
- -------------------------------------------------------------------------------
Read Instructions (on back page) Before Preparing Form. Please Print or Type.
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
- -------------------------------------------------------------------------------
If the notification relates to a portion of the filing checked above, identify
the Items(s) to which the notification relates:
- --------------------------------------------------------------------------------
PART I - REGISTRANT INFORMATION
MICROTECH MEDICAL SYSTEMS, INC.
- --------------------------------------------------------------------------------
Full Name of Registrant
- --------------------------------------------------------------------------------
Former Name if Applicable
2 North Cascade, Suite 330
- --------------------------------------------------------------------------------
Address of Principal Executive Office (Street and Number)
Colorado Springs, CO 80903
- --------------------------------------------------------------------------------
City, State and Zip Code
PART II - RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)
(a) The reasons described in reasonable detail in Part III of
this form could not be eliminated without unreasonable
effort or expense;
- --- (b) The subject annual report, semi-annual report, transition
X report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or
- --- portion thereof, will be filed on or before the fifteenth
calendar day following the prescribed due date; or the
subject quarterly report of transition report on Form 10-Q,
or portion thereof will be filed on or before the fifth
calendar day following the prescribed due date; and
(c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
<PAGE>
PART III - NARRATIVE
State below in reasonable detail the reasons why Form 10-K, 11-K, 10-Q, N-SAR,
or the transition report or portion thereof could not be filed within the
prescribed period.
In connection with the recent change in control and management of the
Registrant, the Registrant and its independent auditors have experienced a delay
in preparing and reviewing the Registrant's financial statements for the quarter
ended June 30, 1996.
PART IV - OTHER INFORMATION
Name and telephone number of person to contact in regard to this notification.
Bruce P. Johnson (510) 273-8750
- ---------------------------------------- --------------- -----------------------
(Name) (Area Code) (Telephone Number)
Have all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of
1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If answer is no,
identify report(s).
--- ---
X Yes No
--- ---
- --------------------------------------------------------------------------------
Is it anticipated that any significant change in results of operations from the
corresponding period for the last fiscal year will be reflected by the earnings
statements to be included in the subject report or portion thereof?
--- ---
Yes X No
--- ---
If so, attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.
- --------------------------------------------------------------------------------
MICROTECH MEDICAL SYSTEMS, INC.
--------------------------------------------
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.
Date August 14, 1996 By /s/ J. Royce Renfrow
----------------------------------- ---------------------------------
INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.
- -----------------------------------ATTENTION------------------------------------
Intentional misstatements or omissions of fact constitute Federal Criminal
Violations (See 18 U.S.C. 1001).
- --------------------------------------------------------------------------------
GENERAL INSTRUCTIONS
1 .This form is required by Rule 12b-25 (17 CFR 240.12b-25) of the General Rules
and Regulations under the Securities Exchange Act of 1934.
2. One signed original and four conformed copies of this form and amendment
thereto must be completed and filed with the Securities and Exchange
Commission, Washington, D.C. 20549, in accordance with Rule O-3 of the
General Rules and Regulations under the Act. The information contained in or
filed with the form will be made a matter of public record in the Commission
files.
3. A manually signed copy of the form and amendments thereto shall be filed
with each national securities exchange on which any class of securities of
the registrant is registered.
4. Amendments to the notifications must also be filed on Form 12b-25 but need
not restate information that has been correctly furnished. The form shall be
clearly identified as an amended notification.
5. Electronic Filers. This form shall not be used by electronic filers unable
to timely file a report solely due to electronic difficulties. Filers unable
to submit a report within the time period prescribed due to difficulties in
electronic filing should comply with either Rule 201 or Rule 202 of
Regulation S-T ('232.201 or '232.202 of this chapter) or apply for an
adjustment in filing date pursuant to Rule 13(b) of Regulations S-T
('232.13(b) of this chapter).
